MiCount System

About MiCareo

MiCareo is a private, commercial-stage diagnostics company specializing in advanced liquid biopsy systems for rare cell analysis. Its core technology platform, centered on the ensemble-decision aliquot ranking (eDAR) method, enables the automated capture and multiplexed imaging of live circulating tumor cells and immune cells with high purity. The company offers two main product systems: the MiSelect R II for cell isolation and the MiCount for AI-driven cell detection, targeting applications in drug development and clinical research. MiCareo is positioned in the growing liquid biopsy market, providing tools for non-invasive, real-time monitoring of cellular-level disease dynamics.

Therapeutic Areas